APA (7th ed.) Citation

Alvarado-Villacorta, R., Merayo-Lloves, J., Sánchez-Ávila, R. M., Alfonso-Bartolozzi, B., Lisa, C., Fernández-Vega-Cueto, L., . . . Anitua, E. (2025). Real-World Outcomes of Allogeneic Immunosafe Plasma Rich in Growth Factors Eye Drops for Refractory Ocular Surface Diseases: A Prospective Observational Study. Ophthalmology & Therapy, 14(9), 2253. https://doi.org/10.1007/s40123-025-01211-1

Chicago Style (17th ed.) Citation

Alvarado-Villacorta, Rosa, Jesús Merayo-Lloves, Ronald M. Sánchez-Ávila, Belén Alfonso-Bartolozzi, Carlos Lisa, Luis Fernández-Vega-Cueto, José F. Alfonso, and Eduardo Anitua. "Real-World Outcomes of Allogeneic Immunosafe Plasma Rich in Growth Factors Eye Drops for Refractory Ocular Surface Diseases: A Prospective Observational Study." Ophthalmology & Therapy 14, no. 9 (2025): 2253. https://doi.org/10.1007/s40123-025-01211-1.

MLA (9th ed.) Citation

Alvarado-Villacorta, Rosa, et al. "Real-World Outcomes of Allogeneic Immunosafe Plasma Rich in Growth Factors Eye Drops for Refractory Ocular Surface Diseases: A Prospective Observational Study." Ophthalmology & Therapy, vol. 14, no. 9, 2025, p. 2253, https://doi.org/10.1007/s40123-025-01211-1.